Demelash Areda

Dr. Demelash Areda

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
AMAdrian Muwonge
Adrian Muwonge
TJTone B Johansen
Tone B Johansen
EVEdvardsen Vigdis
Edvardsen Vigdis
JGJacques Godfroid
Jacques Godfroid
FOFrancisco Olea-Popelka
Francisco Olea-Popelka
BDBerit Djønne
Berit Djønne
Bovine tuberculosis (TB) caused by Mycobacterium bovis is primarily a disease of ruminants, particularly cattle (Bos primigenius) and buffalo (Syncerus caffer), and is endemic in most developing countries. To date, studies done in Uganda have documented the prevalence of M. bovis in cattle, humans and wild life, in addition to non-tuberculous mycobacteria in pigs. Pigs are increasingly becoming an important component of the livestock sector and share the human ecosystem in rural Uganda. It is therefore of public health interest that they are not a source of human infections. As a follow up to previously published findings on mycobacteria in pigs, this study was aimed at investigating the occurrence and molecular characteristics of M. bovis detected in slaughter pigs in Mubende district, Uganda. One hundred fifty mesenteric lymph nodes with lesions suggestive of mycobacterial infections were collected from approximately one thousand slaughtered pigs in Mubende district over a period of five months. The isolation and identification of M. bovis was done using conventional mycobacteriological methods. Mycobacteria belonging to the Mycobacterium tuberculosis complex (MTC) were identified to species level using deletion analysis. Molecular typing was done using Spoligotyping and MIRU-VNTR analysis. Molecular data were analysed and interpreted using MIRU-VNTR plus, SpolDB4.0 and the Mycobacterium bovis spoligo database.

29 October 2018 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
THTakele Habitu
Takele Habitu
DADemelash Areda
Demelash Areda
AMAdrian Muwonge
Adrian Muwonge
GTGirum T. Tessema
Girum T. Tessema
ESEystein Skjerve
Eystein Skjerve
TGTadesse Gebrehiwot
Tadesse Gebrehiwot

9 March 2012 in Tropical Animal Health and Production
Verified
Journal Article
Closed access
PDF file
DADemelash Areda
Demelash Areda
ABAsseged Bogale
Asseged Bogale
JGJacques Godfroid
Jacques Godfroid
ESEystein Skjerve
Eystein Skjerve

1 April 2014 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
DADemelash Areda
Demelash Areda
TJTone Bjordal Johansen
Tone Bjordal Johansen
JGJacques Godfroid
Jacques Godfroid
AMAdrian Muwonge
Adrian Muwonge
ESEystein Skjerve
Eystein Skjerve
BDBerit Djønne
Berit Djønne


18 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
David LUPANDE MwenebituDavid LUPANDE Mwenebitu
David LUPANDE Mwenebitu
DADemelash Areda
Demelash Areda
PAPascal Adroba
Pascal Adroba
FMFrancklin Mwamba
Francklin Mwamba
PKPhilippe BORIBO KIKUNDA
Philippe BORIBO KIKUNDA
GNGaylord AMANI NGABOYEKA
Gaylord AMANI NGABOYEKA
In May 2026, the Democratic Republic of the Congo declared an outbreak of Bundibugyo virus disease (BVD) caused by Bundibugyo ebolavirus (BDBV), for which no licensed vaccine or antiviral treatment was available. We analysed the epidemic trajectory through 14 July 2026 and developed conditional six-month projections. Aggregated data from official INSP/COUSP Situation Reports (14 May–14 July 2026), supplemented by WHO and UN reports, were used to describe cases, deaths, case-fatality ratios (CFRs), and geographic spread. Log-linear models estimated phase-specific growth rates and doubling times; logistic, Gompertz, and constant-incidence scenarios were used for projections, with model comparison, Bayesian sensitivity analysis, deterministic sensitivity bounds, CFR confidence intervals, and rolling-origin validation. Confirmed cases increased from 8 to 2,073, with 796 deaths (national CFR, 38.4%), while affected health zones increased from 3 to 45 across five provinces. Doubling time increased from 8.9 to 19.5 and 25.1 days, representing a 64.1% reduction in growth rate. Ituri accounted for 89.9% of cases, while North Kivu had a CFR of 58.7%. Six-month projections ranged from 2,624 cases under rapid containment to 3,942 under continued deceleration and 10,839 with persistent recent incidence. Although proportional growth slowed, transmission and geographic expansion remained active. The divergence between modelling approaches and systematic under-prediction in temporal validation indicate substantial forecast uncertainty; projections should therefore be interpreted as conditional planning scenarios rather than deterministic forecasts.